Document Detail


Modulation of noradrenaline release in the pithed rabbit: a role for angiotensin II.
MedLine Citation:
PMID:  6209496     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study in the pithed rabbit with electrically stimulated sympathetic outflow (spinal region, T-8; 3 Hz) was conducted to determine the contribution of the renin-angiotensin system to noradrenaline release in vivo. The rate of noradrenaline release (spillover) into the plasma was determined from the endogenous plasma noradrenaline level and the simultaneously determined noradrenaline plasma clearance. In the pithed rabbit, infusion of angiotensin II (0.1 microgram/kg/min i.v.) failed to increase the noradrenaline release rate and only slightly increased blood pressure. On the other hand, the angiotensin-converting enzyme inhibitor captopril (1 mg/kg i.v.) decreased both blood pressure and the noradrenaline release rate. Bilateral nephrectomy was performed to reduce endogenous angiotensin II formation; and in this case, infusion of angiotensin II markedly increased the noradrenaline release rate and blood pressure, whereas captopril had no effect on either parameter. These results suggest that angiotensin II modulates noradrenaline release in vivo through activation of facilitatory prejunctional angiotensin II receptors, and that in the pithed rabbit these receptors are probably maximally activated by endogenously synthesized angiotensin II. The actions of angiotensin II on noradrenaline release open the possibility that increases in blood pressure in the pithed rabbit--by decreasing renin release via intrarenal baroreceptors and hence decreasing angiotensin II formation--may lead to decreased noradrenaline release. This was investigated using phenylephrine (6 micrograms/kg/min i.v.), a selective alpha 1-adrenoceptor agonist, and adrenaline (1 microgram/kg/min i.v.), and alpha 1/alpha 2-agonist. Both drugs increased blood pressure and decreased the noradrenaline release rate. After bilateral nephrectomy, the inhibitory effect of phenylephrine on noradrenaline release was abolished, whereas that of adrenaline was maintained.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
H Majewski; L Hedler; C Schurr; K Starke
Related Documents :
17822786 - Hypothalamic angiotensinergic-noradrenergic systems interaction in fructose induced hyp...
10694186 - Acute production of vascular superoxide by angiotensin ii but not by catecholamines.
443416 - Anteroventral third ventricle lesions reduce antidiuretic responses to angiotensin ii.
20811386 - Levosimendan improves cardiac function and survival in rats with angiotensin ii-induced...
23284906 - The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled tr...
9925906 - Role of nitric oxide in cardiovascular responses to endotoxemia in neonatal lambs.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  6     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:    1984 Sep-Oct
Date Detail:
Created Date:  1984-12-28     Completed Date:  1984-12-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  888-96     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II / pharmacology,  physiology*
Animals
Blood Pressure / drug effects
Captopril / pharmacology
Decerebrate State
Electric Stimulation
Epinephrine / pharmacology
Female
Male
Mecamylamine / pharmacology
Nephrectomy
Norepinephrine / secretion*
Phenylephrine / pharmacology
Rabbits
Renin / secretion
Saralasin / pharmacology
Sympathetic Nervous System / secretion
Chemical
Reg. No./Substance:
11128-99-7/Angiotensin II; 34273-10-4/Saralasin; 51-41-2/Norepinephrine; 51-43-4/Epinephrine; 59-42-7/Phenylephrine; 60-40-2/Mecamylamine; 62571-86-2/Captopril; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, o...
Next Document:  Vasodilator effect of terbutaline: in vivo evidence for the existence of beta 2-adrenoceptors in the...